Finding a Mate

Available Two-hybrid Systems Graphic: Leza BerardoneGenome sequencing has produced a vast supply of proteins in need of a functional identity. One way to identify a protein's function is to identify its interacting partners, because proteins often work in pairs or as part of large complexes. Scientists traditionally have used biophysical or biochemical methods (such as affinity chromatography or co-immunoprecipitation) to study protein-protein interactions. More recently, two-hybrid and phage-d

Written byBarbara Cunningham
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

The two-hybrid system is an in vivo assay, so proteins are more likely to be in their native conformation, and weak and/or transient interactions that may evade detection in vitro can be detected. Conventional two-hybrid systems are based on the fact that many eukaryotic transcriptional activators contain two physically and functionally separate domains, both of which are required for activity. The DNA-binding domain (DBD) binds to specific cis-regulatory sequences, whereas the activation domain (AD) recruits and instructs RNA polymerase II to transcribe downstream genes. While the DBD and AD are generally part of the same protein, as in the native yeast GAL4 protein, they may also function separately provided they are linked in some way that tethers the AD to the promoter.

The standard yeast two-hybrid system identifies an interaction between two proteins by reconstituting active GAL4 protein.1 The two proteins are expressed as fusions with the GAL4 DBD and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies